[Recent clinicopathophysiological status and treatment in Wegener's granulomatosis].
Yoshida
Masaharu
M
Division of Nephrology, Hachioji Medical Center of Tokyo Medical University.
D019268:Antibodies, Antineutrophil Cytoplasmic; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage; D014890:Granulomatosis with Polyangiitis / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D053146:Myeloblastin; D011239:Prednisolone / Q000008:administration & dosage; D012015:Reference Standards; D012697:Serine Endopeptidases / Q000276:immunology
D019268:Antibodies, Antineutrophil Cytoplasmic; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D012697:Serine Endopeptidases; D053146:Myeloblastin